DE69216642D1 - Verfahren zur herstellung von tabletten mit hoher festigkeit - Google Patents

Verfahren zur herstellung von tabletten mit hoher festigkeit

Info

Publication number
DE69216642D1
DE69216642D1 DE69216642T DE69216642T DE69216642D1 DE 69216642 D1 DE69216642 D1 DE 69216642D1 DE 69216642 T DE69216642 T DE 69216642T DE 69216642 T DE69216642 T DE 69216642T DE 69216642 D1 DE69216642 D1 DE 69216642D1
Authority
DE
Germany
Prior art keywords
high strength
producing tablets
binder
tablet
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69216642T
Other languages
English (en)
Other versions
DE69216642T2 (de
Inventor
Julian Lo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69216642D1 publication Critical patent/DE69216642D1/de
Application granted granted Critical
Publication of DE69216642T2 publication Critical patent/DE69216642T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
DE69216642T 1992-01-13 1992-09-10 Verfahren zur herstellung von tabletten mit hoher festigkeit Expired - Fee Related DE69216642T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81955392A 1992-01-13 1992-01-13
PCT/US1992/007497 WO1993013758A1 (en) 1992-01-13 1992-09-10 Preparation of tablets of increased strength

Publications (2)

Publication Number Publication Date
DE69216642D1 true DE69216642D1 (de) 1997-02-20
DE69216642T2 DE69216642T2 (de) 1997-05-07

Family

ID=25228458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69216642T Expired - Fee Related DE69216642T2 (de) 1992-01-13 1992-09-10 Verfahren zur herstellung von tabletten mit hoher festigkeit

Country Status (12)

Country Link
US (1) US5853758A (de)
EP (1) EP0620728B1 (de)
JP (1) JP2640570B2 (de)
AT (1) ATE147261T1 (de)
CA (1) CA2117351C (de)
DE (1) DE69216642T2 (de)
DK (1) DK0620728T3 (de)
ES (1) ES2096103T3 (de)
FI (1) FI109086B (de)
GR (1) GR3022458T3 (de)
PT (1) PT101175B (de)
WO (1) WO1993013758A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
AU682764B2 (en) * 1994-04-01 1997-10-16 Tsumura & Co. Process for producing sustained-release tablets and enteric tablets
SK167597A3 (en) * 1995-06-07 1998-10-07 Quadrant Holdings Cambridge Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6413541B1 (en) 1999-01-13 2002-07-02 Dainippon Pharmaceutical Co., Ltd. Disintegrating tablet in oral cavity and production thereof
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB2350582A (en) * 1999-06-01 2000-12-06 Hiran Asoka Malinga Ratwatte A method of tableting
US6277409B1 (en) 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US6258381B1 (en) 2000-02-11 2001-07-10 Mcneil-Ppc, Inc. Tablet and process for making the same
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
US20100015246A1 (en) * 2000-06-27 2010-01-21 Shire International Licensing B.V. Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (de) * 2001-01-26 2002-07-31 Pfizer Products Inc. Arzneiform mit verbesserten kohäsiven und kompressiven Eigenschaften
JP4515030B2 (ja) * 2001-04-23 2010-07-28 アノーメッド インコーポレイティド 腎臓結石疾患の予防のための希土類化合物の使用
EP1323417B1 (de) * 2001-05-10 2006-07-19 Astellas Pharma Inc. In der mundhöhle schnell zerfallende tabletten und prozess zu deren herstellung
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US7914811B2 (en) 2001-06-29 2011-03-29 Mcneil-Ppc, Inc. Brittle-coating, soft core dosage form
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US7993674B2 (en) * 2002-02-13 2011-08-09 Weibel Michael K Drug dose-form and method of manufacture
GB0204772D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Pharmaceutical dosage forms
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
AU2004266050B2 (en) * 2003-08-26 2009-06-18 Takeda Pharmaceutical Company Limited Pharmaceutical formulation comprising lanthanum compounds
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US8591974B2 (en) * 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
KR101072196B1 (ko) * 2004-07-27 2011-10-10 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070104799A1 (en) * 2005-11-09 2007-05-10 Shire International Licensing B.V. Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20070259052A1 (en) * 2006-05-05 2007-11-08 Shire International Licensing B.V. Assay for lanthanum hydroxycarbonate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
WO2009058798A2 (en) 2007-10-31 2009-05-07 Mcneil-Ppc, Inc. Orally disintegrated dosage form
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
CN108159019A (zh) 2009-12-02 2018-06-15 阿黛尔药物有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
EP2701532B1 (de) 2011-04-29 2017-11-15 Intercontinental Great Brands LLC Eingekapselte säure, verfahren zu ihrer herstellung und kaugummi damit
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
BR112016015944A8 (pt) 2014-01-10 2020-06-09 Johnson & Johnson Consumer Inc processo para produzir comprimido, que usa radiofrequência e partículas revestidas dissipadoras de energia
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
EP3389628A4 (de) 2015-12-19 2019-08-07 Dixit, Manesh A. Pharmazeutische formulierungen in form von weichen kautabletten
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
DK3576718T3 (da) * 2017-02-01 2021-08-23 Johnson & Johnson Consumer Inc Pastil
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
JP7145121B2 (ja) 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
NL297357A (de) * 1962-08-31
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE1617593A1 (de) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Verfahren zur Herstellung von Tabletten oder Pillen
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
ES403326A1 (es) * 1971-06-04 1975-05-01 Boehringer Mannheim Gmbh Procedimiento para la granulacion de masas para tabletas enforma de polvo.
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
FR2231365B1 (de) * 1973-05-29 1977-11-04 Hoffmann La Roche
US3961004A (en) * 1974-04-11 1976-06-01 Auburn Research Foundation Method of tabletting using gluconolactone as the direct compression diluent
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4166107A (en) * 1978-07-25 1979-08-28 The United States Of America As Represented By The Secretary Of Agriculture Sustained release bolus formulations containing insect growth regulators for control of livestock pests
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
LU87233A1 (fr) * 1988-06-07 1990-02-28 Pharlyse Sa Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
DE69200474T2 (de) * 1991-01-03 1995-02-02 Glaxo Canada Verfahren zur herstellung einer festem pharmazeutischen zusammensetzung.

Also Published As

Publication number Publication date
EP0620728A1 (de) 1994-10-26
CA2117351C (en) 1998-03-03
ES2096103T3 (es) 1997-03-01
US5853758A (en) 1998-12-29
EP0620728B1 (de) 1997-01-08
JPH07503237A (ja) 1995-04-06
FI943327A0 (fi) 1994-07-12
PT101175A (pt) 1994-03-31
FI943327A (fi) 1994-07-12
CA2117351A1 (en) 1993-07-22
WO1993013758A1 (en) 1993-07-22
PT101175B (pt) 1999-09-30
ATE147261T1 (de) 1997-01-15
JP2640570B2 (ja) 1997-08-13
DE69216642T2 (de) 1997-05-07
FI109086B (fi) 2002-05-31
GR3022458T3 (en) 1997-04-30
DK0620728T3 (da) 1997-07-07

Similar Documents

Publication Publication Date Title
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
ES2020890A6 (es) Procedimiento de preparacion de una composicion farmaceutica en forma de microparticulas.
HU9204033D0 (en) Substituted benzimidazoles, method for producing them and their pharmaceutical application
DE69023896T2 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
IL117532A0 (en) Production of compositions in the form of a solid solution of an active substance in a polymer matrix
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
DE69107949D1 (de) MOS-gesteuerter Thyristor und Verfahren zu dessen Herstellung.
DE3850800D1 (de) Supraleitendes Material und Verfahren zu dessen Herstellung.
NL8901652A (nl) Carboxamideverbindingen, werkwijzen ter bereiding hiervan en farmaceutische preparaten, die deze bevatten.
DE68917625D1 (de) Verbundmaterial und Verfahren zu dessen Herstellung.
HU9203828D0 (en) Method for producing cristallic alpha-2-interferon
DE68921246T2 (de) Gesinterte, oberflächenveredelte Legierung mit und ohne Hartbeschichtung sowie Verfahren zur Herstellung der Legierung.
DE3874358T2 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
DE69001573D1 (de) Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
DE3879536D1 (de) Supraleitender keramischer film und verfahren zu dessen herstellung.
DE69427457D1 (de) Yttrium-enthaltendes Verbundpulver, gesinterter Verbundwerkstoff, und Verfahren zu dessen Herstellung
DE3877881T2 (de) Sic-a12o3-sinterverbundkoerper und verfahren zu ihrer herstellung.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE59404552D1 (de) Sinterkontaktwerkstoff, verfahren zu dessen herstellung sowie diesbezügliche kontaktauflagen
DE3867075D1 (de) 2-alkylsulfinyl-4(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
DE3380989D1 (de) 2-aminobenzosaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen.
GB2206343B (en) Smoke producing composition for pyrotechnic markers, method for the production thereof and pyrotechnic markers containing same.
HU9202975D0 (en) Dihydro-pyridines substituted by indole-sulfonamide, method for producing them and their application in pharmaceutical preparatives
DE3869660D1 (de) Ionomerzusammensetzung und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee